Olumiant (baricitinib) is a Janus kinase (JAK) inhibitor that is used to treat adults with severe alopecia areata. Baricitinib is also prescribed to treat adult patients with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response to one or more tumor necrosis factor (TNF) blockers.